Recent disclosures reveal that Glenmark Pharmaceuticals has been forced to recall tens of millions of atomoxetine pills due to contamination with carcinogens known as nitrosamines. Drug regulators consider nitrosamines as “high potency mutagenic carcinogens,” the presence of which is “unacceptable” in drugs. These carcinogens result from the drug manufacturing process, and the FDA requires drugmakers like Glenmark to effectively eliminate them from finished drugs.
Millions of American children, adolescents, and their parents depend on atomoxetine (generic Strattera) to manage ADHD and other conditions. Patients trust drug companies like Glenmark with what they put in their bodies. But Glenmark is recalling over 44 million atomoxetine pills that never should have been put on the market in the first place due to contamination.
This is only the latest major recall by Glenmark. For at least the fifth time in a year, Glenmark has sold millions of nitrosamine-contaminated drugs, only later to be forced to recall them when the facts are revealed. In addition, Glenmark has been forced to recall millions of other drugs due to dangerous quality failures, filthy conditions in its factories, and other problems. Glenmark has also received multiple warning letters by the FDA, yet has continued to make and sell defective drugs.
If you take atomoxetine made by Glenmark, you may have legal claims against the company. The Block Firm is investigating a potential class action against Glenmark, which is an important tool for maintaining the integrity of the U.S. drug supply system. However, please do not stop taking your medication without consulting with your physician, who will be able to guide you about the risks and benefits of your specific medication regimen.
If you are interested in learning more, please contact the experienced class action attorneys at The Block Firm.
